Plastic and behavioral abnormalities in experimental Huntington's disease: a crucial role for cholinergic interneurons.
about
Striatal cholinergic interneuron regulation and circuit effectsCholinergic interneurons are differentially distributed in the human striatumBDNF-TrkB signaling in striatopallidal neurons controls inhibition of locomotor behavior.Cholinergic neuronal defect without cell loss in Huntington's disease.A small molecule p75NTR ligand normalizes signalling and reduces Huntington's disease phenotypes in R6/2 and BACHD mice.Reversal of plasticity-like effects in the human motor cortexEnhanced GABAergic Inputs Contribute to Functional Alterations of Cholinergic Interneurons in the R6/2 Mouse Model of Huntington's DiseaseThe corticostriatal pathway in Huntington's disease.M4 Muscarinic Receptor Signaling Ameliorates Striatal Plasticity Deficits in Models of L-DOPA-Induced DyskinesiaStriatal plasticity and basal ganglia circuit function.Cholinergic Interneurons Amplify Corticostriatal Synaptic Responses in the Q175 Model of Huntington's Disease.Neurotransmitter roles in synaptic modulation, plasticity and learning in the dorsal striatumBrain networks in Huntington disease.Pathophysiology of Huntington's disease: time-dependent alterations in synaptic and receptor function.Tardive dyskinesia is caused by maladaptive synaptic plasticity: a hypothesis.New synaptic and molecular targets for neuroprotection in Parkinson's disease.Dopamine imbalance in Huntington's disease: a mechanism for the lack of behavioral flexibility.Striatal cholinergic interneurons and cortico-striatal synaptic plasticity in health and disease.Corticostriatal circuit dysfunction in Huntington's disease: intersection of glutamate, dopamine and calcium.Hyperkinetic disorders and loss of synaptic downscaling.Targeting the Cholinergic System to Develop a Novel Therapy for Huntington's DiseaseExtrinsic Sources of Cholinergic Innervation of the Striatal Complex: A Whole-Brain Mapping Analysis.Effects of caffeic acid, rofecoxib, and their combination against quinolinic acid-induced behavioral alterations and disruption in glutathione redox status.Centrality of striatal cholinergic transmission in Basal Ganglia function.Corticostriatal Plastic Changes in Experimental L-DOPA-Induced Dyskinesia.Changes in striatal activity and functional connectivity in a mouse model of Huntington's diseaseXenotransplantation of human adipose derived mesenchymal stem cells in a rodent model of Huntington's disease: motor and non-motor outcomes.Possible nitric oxide modulation in protective effect of FK-506 against 3-nitropropionic acid-induced behavioral, oxidative, neurochemical, and mitochondrial alterations in rat brain.Decreased striatal dopamine release underlies increased expression of long-term synaptic potentiation at corticostriatal synapses 24 h after 3-nitropropionic-acid-induced chemical hypoxia.Ameliorating effect of Celastrus paniculatus standardized extract and its fractions on 3-nitropropionic acid induced neuronal damage in rats: possible antioxidant mechanism.Systemic transplantation of mesenchymal stem cells can reduce cognitive and motor deficits in rats with unilateral lesions of the neostriatum.Protective effect of Convolvulus pluricaulis standardized extract and its fractions against 3-nitropropionic acid-induced neurotoxicity in rats.Exercise-Induced Fatigue Impairs Bidirectional Corticostriatal Synaptic Plasticity.Enzyme-Controlled Nanodevice for Acetylcholine-Triggered Cargo Delivery Based on Janus Au-Mesoporous Silica Nanoparticles.
P2860
Q26863113-864D55BF-8794-4ABE-87B2-F85F595D8674Q28471822-4F09415F-8EAD-46C6-B1C8-585693A0AE4DQ30573241-F7922B48-FAB0-470E-974E-199FA68BD964Q33258207-9D4DBD66-6848-413B-A8A0-347DBE750474Q33640604-35C1366D-D7BC-4006-BE8C-1F9DB5B2EE7EQ34382342-93C1BE74-B783-4A46-B97F-FC995D3F3377Q35867178-0BC3C658-54F4-427A-B38F-DA4E3ED1D2C9Q36684263-8953032A-11EF-45A9-B81F-EE9EB62CC542Q36892615-AA439EDD-23B4-4A1F-A6C4-2046C3366F06Q37336143-00C547C6-FBBE-4B4A-A271-ADB80B98D546Q37507773-283FBA28-16EC-49FB-A811-32C76A056161Q37680104-FF68B424-F579-44F2-8FC1-FC61726FA074Q37834193-031A9B82-E6BB-4D21-9BB0-1383EE6E8C67Q37930190-796E23B2-7436-4ADB-8EF3-8D2E12E91452Q38032249-77191AC1-4780-434A-B8FE-3C589CA4E5EBQ38038559-1010BAE7-F856-454C-AFE5-00570B0622C3Q38121068-13AD599D-29F4-4A82-B239-79F8C53E4CC4Q38533480-C4E3DDC8-F13F-4C1D-8216-C44301CA4ED7Q38603960-C5FC5C51-2634-4A3C-B54C-C06737D7D169Q38847727-E9206799-558A-493B-B71C-666B1B8B5AEDQ39041214-762144C1-C6B7-4A88-A531-2C11EBA61A6FQ40936443-7674CAC6-260A-421D-A458-54B5ABAB5AD6Q41350923-4E8C760F-ED3D-4BE3-8A2E-D622A5BDC81AQ41915908-D4E468F8-F003-4C7F-A029-D086D41E3EA8Q42177230-A70D9597-C27C-4AA7-9F0C-B6F1645BA447Q42190041-B49D98D8-04F5-42D0-88A0-28968B20F0BAQ42692081-1F6784C0-670D-4731-A108-4C8793D001B5Q43021497-96AF1B26-9698-44C4-9CF3-1C6EB3C18A4FQ43073344-E7A51BAD-7DB1-4D19-AC9C-A0FB005EFC8AQ45300396-2ACF2548-C4BE-453C-81E1-F0D228CAE2C2Q45943807-E1BA3C37-400D-4655-8636-E7B7A85C3E9DQ48240057-81DA8C2B-47D3-4EAE-B0F6-E439A1EC6293Q49193847-5B70FEEC-1A8C-435E-97D2-2E81C022C4ECQ53490437-C1AF834E-172A-4C11-A64F-3E08B8636E5E
P2860
Plastic and behavioral abnormalities in experimental Huntington's disease: a crucial role for cholinergic interneurons.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Plastic and behavioral abnorma ...... for cholinergic interneurons.
@en
Plastic and behavioral abnorma ...... for cholinergic interneurons.
@nl
type
label
Plastic and behavioral abnorma ...... for cholinergic interneurons.
@en
Plastic and behavioral abnorma ...... for cholinergic interneurons.
@nl
prefLabel
Plastic and behavioral abnorma ...... for cholinergic interneurons.
@en
Plastic and behavioral abnorma ...... for cholinergic interneurons.
@nl
P2093
P50
P1476
Plastic and behavioral abnorma ...... for cholinergic interneurons.
@en
P2093
Antonio Pisani
Carmelo Sgobio
Enrica Passino
Giorgio Bernardi
Ilaria Barone
Martine Ammassari-Teule
Paolo Calabresi
P304
P356
10.1016/J.NBD.2005.10.009
P577
2005-12-02T00:00:00Z